Milk production losses in Latxa dairy sheep associated with small ruminant lentivirus infection.

Visna/Maedi is a disease of sheep caused by small ruminant lentivirus (SRLV) infection that is widespread throughout the world and that has been recognized to be present in the Basque Country (Spain) since the early 1980's. Nearly seven decades of studies have improved the knowledge on its clinical signs and epidemiology. However, its slow progressive nature, subclinical most of the time, makes difficult to assess its real impact on productive traits, a question of critical importance to balance out the economic costs it causes and the benefits of designing and deploying an eradication program. Development of a dairy breeding program since the 90 s in the local Latxa sheep population has provided data on milk productivity in several flocks where SRLV infection prevalence has been continuously monitored. This study analyses retrospectively the association between SRLV prevalence and production variables during ten yearly lactations in three Latxa dairy flocks with medium-high SRLV seroprevalence. Our results indicate that average standard lactation of seropositive sheep was 6.7 % lower than controls. The largest differences (p < 0.001) were observed at the ewe lifetime peak of production between second and fourth lactations. Lifelong milk and lamb production data indicated even a higher impact, with costs rising up to nearly 50 €/ewe/year. This substantial production decrease associated with subclinical SRLV infection in Latxa dairy sheep supports the benefit of establishing a SRLV control program. A rough cost-benefit analysis indicated that even in a medium-yielding breed, testing expenses would be largely covered by milk production improvement.

Artrite encefalite caprina: avaliação dos aspectos produtivos e reprodutivos de animais infectados e não infectados / Caprine arthritis encephalitis: productive and reproductive aspects evaluation in infected and not infected goats

O objetivo foi avaliar os aspectos produtivos e reprodutivos, de caprinos leiteiros, reagentes e não reagentes à prova de imunodifusão em ágar gel (IDAG), utilizando os antígenos gp135 e p28 do vírus da Artrite Encefalite Caprina (CAE). Os animais pertenciam a uma propriedade localizada no interior de São Paulo e foram acompanhados por um período de 24 meses, tendo sido realizados 3 testes sorológicos, com intervalos de 12 meses. A freqüência de ocorrência da CAE, nos três momentos foi respectivamente, 60,1%, 74,1 %, e 70,5% (média de 68,3% - 566/829). O percentual de animais reagentes aumentou significativamente com a idade. A duração média da lactação (dias) foi menor para reagentes e significativa nas faixas etárias 24 a 36 meses e 36 a 48 meses. A produção leiteira (kg./ dia) foi menor para reagentes e significativanas faixas etárias: 12 a 24 meses maior ou igual a 48 meses. A produção total por lactação foi 21,5% menor para as cabras soropositivas. A CAE não influenciou os aspectos reprodutivos neste estudo no que se refere à idade ao primeiro parto, ao intervalo interpartos. No entanto, a média de idade ao parto entre os animais reagentes foi maior e estatisticamente significante e o peso das crias nascidas de mães reagentes com idade maior ou igual a 48 meses foi menor do que os animais nascidos de cabras não reagentes.

Routes of transmission and consequences of small ruminant lentiviruses (SRLVs) infection and eradication schemes.

Small ruminant lentiviruses (SRLV = maedi-visna in sheep and caprine arthritis encephalitis in goats) are distributed throughout most countries of the world, particularly Europe. Laboratories from 16 European countries established collaborations within the framework of a COST (CO-operation in the field of Scientific and Technical Research) action sponsored by the European Union in order to (i) better organize their research programmes on SRLVs and (ii) to coordinate efforts to combat these two diseases. After five years, a consensus conference--the first one in the veterinary medicine field--concluded the work of this network of laboratories by reviewing the present position and discussing three important questions in the field of SRLVs: routes of transmission, consequences of infection and potential role of eradication programmes at either a European or local level, according to the situation in each country or region. This paper brings together existing information regarding these questions and identifies areas for future research.